本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Atea Pharmaceuticals, Inc.

5.31
+0.13002.51%
盤後5.310.00000.00%18:44 EDT
成交量:48.96萬
成交額:258.80萬
市值:4.26億
市盈率:-2.53
高:5.41
開:5.23
低:5.18
收:5.18
52周最高:6.45
52周最低:2.78
股本:8,020.47萬
流通股本:6,005.23萬
量比:1.88
換手率:0.82%
股息:- -
股息率:- -
每股收益(TTM):-2.0959
每股收益(LYR):-1.9430
淨資產收益率:-58.14%
總資產收益率:-36.72%
市淨率:2.09
市盈率(LYR):-2.73

資料載入中...

2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/28

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/10/02

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report